PEHA logo

PT Phapros Tbk Stock Price

IDX:PEHA Community·Rp233.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

PEHA Share Price Performance

Rp0
-288.00 (-100.00%)
Rp0
-288.00 (-100.00%)
Price Rp0

PEHA Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Good value with low risk.

3 Risks
1 Reward

PT Phapros Tbk Key Details

Rp856.1b

Revenue

Rp520.8b

Cost of Revenue

Rp335.3b

Gross Profit

Rp544.9b

Other Expenses

-Rp209.6b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-249.48
39.17%
-24.48%
178.8%
View Full Analysis

About PEHA

Founded
1954
Employees
1264
CEO
Ida Kurniasih
WebsiteView website
www.phapros.co.id

PT Phapros Tbk, together with its subsidiaries, operates in the pharmaceutical industry in Indonesia. The company operates through Ethical; Over the Counter (OTC) Drugs; Generic Drugs Bearing (OCB); and Toll-in segments. It offers OTC drugs, including Antimo Anak, Antimo tablet, Livron B Plex, X-Gra, Becefort Sirop and tablet, Noza, Febrinex, Betafort suspensi, and Hemorogard. The company also provides ethical generic and branded products; and medical devices, as well as toll manufacturing. It also exports its products. The company was founded in 1954 and is headquartered in Jakarta Selatan, Indonesia. PT Phapros Tbk is a subsidiary of PT Kimia Farma Tbk.

Recent PEHA News & Updates

Recent updates

No updates

PT Phapros Tbk Competitors